Phenelzine use throughout pregnancy and the puerperium: Case report, review of the literature, and management recommendations

Depression and Anxiety

Volumn 6, Issue 3, 1997, Pages 124-128

  Gracious, Barbara L ^a   Wisner, Katherine L ^b  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Anesthesia; Labor and delivery; Major depression; Monoamine oxidase inhibitors; Phenelzine; Pregnancy

Indexed keywords

ETOMIDATE; FENTANYL; HYDRALAZINE; KETAMINE; METHYLDOPA; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NIFEDIPINE; PETHIDINE; PHENELZINE; THIOPENTAL; TRANYLCYPROMINE; TYRAMINE;

ADULT; ARTICLE; BREAST FEEDING; CASE REPORT; CONSTIPATION; DEPRESSION; DOSE CALCULATION; DYSURIA; FEMALE; FETUS MONITORING; HUMAN; HYPERTENSION; INTRAMUSCULAR DRUG ADMINISTRATION; MYOCLONUS; OBESITY; OBSTETRIC ANALGESIA; PRACTICE GUIDELINE; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PUERPERIUM; SUBLINGUAL DRUG ADMINISTRATION; XEROSTOMIA;

EID: 0031426302     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6394(1997)6:3<124::AID-DA6>3.0.CO;2-D     Document Type: Article

References (26)

1. Bergamaschi MMP, Berlingieri D (1968) Traitement neuroleptique au dobut de la grossesse et teratone sacrococcygien du foetus. Bulletin Federale Societe Gynecologie et Obstetrica 20:316-318.
2. Burke KC, Burke JD, Rae, DS, Regier DA (1991) Comparing age at onset of major depression and other psychiatric disorders by birth cohorts in five US community populations. Arch Gen Psychiatry 48:789-795.
3. Davidson J (1983) MAO inhibitors: a clinical perspective. In Ayd FJ, Taylor IJ, Taylor BT (eds): Affective Disorders Reassessed. Baltimore: Ayd Medical Communications, pp 41-55.
4. Davidson J, Pelton S (1986) Forms of atypical depression and their response to antidepressant drugs. Psychiatry Res 17:87-95.
5. Doyle JD (1990) Ketamine induction and monoamine oxidase inhibitors. J Clin Anesth 2:324-325.
6. El-Ganzouri AT, Ivankovich AD, Braverman B, McCarthy R (1985) Mono-amine oxidase inhibitors: Should they be discontinued preoperatively? Anesth Analg 64:592-596.
7. Goldstein DJ, Marvel DE (1993) Psychotropic medications during pregnancy: Risk to the fetus (letter). JAMA 270:2177.
8. Heinonen OP, Slone D, Shapiro S (1977) Birth Defects and Drugs in Pregnancy. Littleton: Publishing Sciences Group.
9. Janowsky, EC, Risch SC, Janowsky DS (1981) Psychotropic Agents. In Smith NT, Miller RD, Carbascio AW (eds): Drub Interactions in Anesthesia. Philadelphia: Lea and Febiger, pp 177-195.
10. Knuppel RA, Drukker J (1993) High Risk Pregnancy: A Team Approach. Philadelphia: Saunders.
11. Landy HJ, Weiner S, Corson SL, Batzer FR, Bolognese RJ (1986) The "vanishing twin": Ultrasonographic assessment of fetal disappearance in first trimester. Am J Obstet Gynecol 155:149.
12. Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison WM, Markowitz, JS, Rabkin JG, Tricamo E, Goetz DM, Klein DF (1988) Antidepressant specificity in atypical depression. Arch Gen Psychiatry 45:129-137.
13. Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison W, Rabkin J, Tricamo E, Markowitz JS, Klein DF (1984) Phenelzine v imipramine in atypical depression. Arch Gen Psychiatry 41:669-677.
14. Michaels I, Serrins M, Shier NQ, Barash PG (1984) Anesthesia for cardiac surgery in patients receiving monoamine oxidase inhibitors. Anesth Analg 63:1041-1044.
15. Pastuzak A, Schick-Boschetto B, Zuber C, Feldkamp M, Pinelli M, Sihn S, Donnenfield A, McCormack M, LeenMitchell M, Woodland C, Gardner A, Hom M, Koren G (1993) Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 269:2246-2248.
16. Pavy TJ, Kliffer AP, Douglas MJ (1995) Anaesthetic management of labour and delivery in a woman taking longterm MAOI. Canadian J Anaesthesia 42:618-620.
17. Poulson E, Botros M, Robson JM (1960) Effect of Shydroxytryptamine and iproniazid on pregnancy. Science 131-1101-1102.
18. Poulson E, Robson JM (1963) The effect of amine oxidase inhibitors on pregnancy. J Endocrinol 27:147-155.
19. Ramin SM, Little BB, Gilstrap III LC (1992) Drugs and Pregnancy. New York: Elsevier Science Publishing Company.
20. Roisen MF (1994) Anesthetic Implications of Concurrent Diseases. In RD Miller (ed): Anesthesia, 4th edition. New York: Churchhill Livingstone, pp 903-1014.
21. Roizen MF (1990) Monamine oxidase inhibitors: Are we condemned to relieve history, or is history no longer relevant? J Clin Anesth 2:293-295.
22. Shulman KI, Walker, SE, MacKenzie S, Knowles S (1989) Dietary restriction, tyramine, and the use of monoamine oxidase inhibitors. J Clin Psychopharmacol 9:397-402.
23. Werboff J, Gottlieb JS, Dembicki EL, Havlena J (1961) Postnatal effect of antidepressant drugs administered during gestation. Exp Neurol 3:542-555.
24. Wisner KL, Perel JM (1988) Psychopharmacologic agents and electroconvulsive therapy during pregnancy and the puerperium. In Cohen RL (ed): Psychiatric Consultation in Childbirth Settings. New York: Plenum Publishing Corporation, pp 165-205.
25. Wisner KL, Pere JM, Foglia JP (1995) Serum clomipramine and metabolite levels in four nursing mother-infant pairs. J Clin Psych 56:17-20.
26. Wisner KL, Perel JM, Sheeler SB (1993) Tricyclic dose requirements across pregnancy. Am J Psychiatry 150:1541-1542.